is the most common form of pancreatic cancer. With a dismal,13% five-year survival rate, it is the third leading cause of cancer deaths. One major challenge is the microenvironment surrounding the ...

ABOUT ORPHAN DRUG DESIGNATION The FDA grants Orphan Drug Designation to investigational drugs intended for the treatment of rare diseases affecting fewer than 200,000 people in the U.S. Benefits ...

The fibrotic tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC) increases the failure rate of immune- and chemotherapy by contributing to low immune infiltration and poor ...

Download this application note from 10x Genomics to learn how scientists used a 380-gene immuno-oncology panel to study tumor organization and the tumor microenvironment in ovary, lung, pancreatic, ...

LUND, SE / ACCESS Newswire / June 13, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical-stage biotechnology ...

The team developed pancreatic cancer models using 3D printed "tumoroids" and microfluidic systems that mimic the complex tumor microenvironment—called microfluidic tumor-stroma models—to ...

Pancreatic ductal adenocarcinoma (PDAC) is a type of cancer characterized by very poor prognosis and resistance to immunotherapy due to an immunosuppressive tumor microenvironment, which includes ...